Prasad S. Kulkarni
- Virology top 2%
- Ophthalmology top 1%
- Glaucoma and retinal disorders 12
- Microbiology top 2%
- Bacterial Infections and Vaccines 19
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology 16
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 12
-
- Inflammatory mediators and NSAID effects 24
-
- Virology and Viral Diseases 18
- Pneumonia and Respiratory Infections 13
-
- Vaccine Coverage and Hesitancy 13
- Co-authors
- Balaji SrinivasanPhilip NeedlemanAmiram RazRajeev DhereK.E. EakinsKenneth E. EakinsP. BhattacherjeeSubhash V. Kapre
- Cited by
- VirologyOphthalmologyMicrobiology
- Partner nations
- United StatesIndiaSwitzerland
In The Last Decade
Prasad S. Kulkarni
130 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 136
- Virology 235
- Ophthalmology 443
- Microbiology 251
- Biochemistry 253
- Infectious Diseases 566
Countries citing papers authored by Prasad S. Kulkarni
This map shows the geographic impact of Prasad S. Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasad S. Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasad S. Kulkarni more than expected).
Fields of papers citing papers by Prasad S. Kulkarni
This network shows the impact of papers produced by Prasad S. Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasad S. Kulkarni. The network helps show where Prasad S. Kulkarni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Prasad S. Kulkarni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 27 | |
| 7 | 2021 | 22 | |
| 8 | 2018 | 32 | |
| 9 | 2016 | 9 | |
| 10 | 2015 | 57 | |
| 11 | Different techniques for soil moisture measurement. | 2011 | 1 |
| 12 | 2002 | 12 | |
| 13 | 2001 | 31 | |
| 14 | 1997 | 10 | |
| 15 | 1994 | 14 | |
| 16 | 1992 | 19 | |
| 17 | 1991 | 23 | |
| 18 | 1991 | 16 | |
| 19 | 1987 | 7 | |
| 20 | 1986 | 3 |
About Prasad S. Kulkarni
Prasad S. Kulkarni is a scholar working on Microbiology, Virology and Biochemistry, having authored 135 papers that have together received 3.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (24 papers), Bacterial Infections and Vaccines (19 papers), Virology and Viral Diseases (18 papers), Eicosanoids and Hypertension Pharmacology (16 papers), Vaccine Coverage and Hesitancy (13 papers), Pneumonia and Respiratory Infections (13 papers), Glaucoma and retinal disorders (12 papers) and SARS-CoV-2 and COVID-19 Research (12 papers). The work is most often cited by research in Virology (235 citations), Ophthalmology (443 citations) and Microbiology (251 citations). Prasad S. Kulkarni has collaborated with scholars based in United States, India and Switzerland. Frequent co-authors include Balaji Srinivasan, Philip Needleman, Amiram Raz, Rajeev Dhere, K.E. Eakins, Kenneth E. Eakins, P. Bhattacherjee, Subhash V. Kapre, Beat Müeller and Philipp Schüetz. Their work appears in journals such as Science, New England Journal of Medicine and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.